Abstract
The present study was designed to analyse the scintigraphic appearance of the thyroid in hypothyroid patients with blocking-type TSH receptor antibodies (TRAbs). Eleven hypothyroid patients with autoimmune thyroiditis positive for TSH binding inhibitor immunoglobulins (TBII) [80% ± 12 (SD)%; normal <11%] and for thyroid stimulation-blocking antibodies (TSBAbs) (90% ± 9%; normal <32%) were studied. Thyroid scanning was performed using technetium-99m or iodine-123, when the patients were hypothyroid. Analysis of the scan images revealed the presence of localized functioning areas in six patients (group 1), and no visualization of the thyroid in the remaining five patients (group 2). Patients in group 1 showed significantly higher uptake of 99m-Tc than those in group 2 (P<0.05). Interestingly, three patients in group 1 were positive for thyroid-stimulating antibodies (TSAbs) (249% ± 17%; normal <145%), which were not detected in the remaining eight patients. Antibodies against thyroglobulin and microsomal antigens were detected in nine nine (81.8%) and 11 (100%) patients, respectively, but neither of these titres correlated with the scan image. Three patients in group 1 underwent scintigraphy again after treatment with thyroxine, at which time the functioning lesion was not noted. Fourteen hypothyroid patients with negative TBII displayed no such scintigraphic findings. Chronic stimulation of the thyroid by TSAbs and/or TSH might be responsible for the presence of the functioning lesion, but clarification of the mechanism requires further studies. In summary (1) TSAbs were detected in three (27.3%) of 11 hypothyroid patients with blocking TRAbs; (2) thyroid scintigraphy revealed the presence of localized functioning area(s) in approximately half of these cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 1978; 46:734–739.
Konishi J, Iida Y, Kasagi K, Misaki T, Nakashima T, Endo K, Mori T, Shimpo S, Nohara Y, Matsuura N, Torizuka K. Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins; clinical and laboratory findings in 15 patients. Ann Intern Med 1985; 103: 26–31.
Arikawa K, Ichikawa Y, Yoshida T, Shinozawa T, Homma M, Momotani N, Ito K. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action. J Clin Endocrinol Metab 1985;60:953–959.
Cho BY, Shong YK, Lee HK, Koh C-S, Min HK. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins. Acta Endocrinol (Copenh) 1989; 120: 99–106.
Takasu N, Yamada T, Takasu M, Komiya I, Nagasawa I, Asawa T, Shinoda T, Aizawa T, Koizumi Y. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992; 326: 513–518.
Konishi J, Kasagi K, Iida Y, Kousaka T, Misaki T, Arai K, Tokuda Y, Torizuka K. Optimization and clinical assessment of a radioreceptor assay for thyrotropin-binding inhibitor immunoglobulins. Endocrinol Japon 1987; 134: 13–20.
Kasagi K, Konishi J, Iida Y, Tokuda Y, Arai K, Endo K, Torizuka K. A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells. Acta Endocrinol (Copenh) 1987; 115:30–36.
Kasagi K, Hidaka A, Nakamura H, Takeuchi R, Misaki T, Iida Y, Konishi J. Thyrotropin receptor antibodies in hypothyroid Graves' disease. J Clin Endocrinol Metab 1993; 75: 504–508.
Tamai H, Kasagi K, Takaichi Y, Takamatsu J, Matsubayashi S, Konishi J, Kuma K, Kumagai LF, Nagataki S. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 1989;69:49–53.
Tokuda Y, Kasagi K, Iida Y, Hatabu H, Misaki T, Arai K, Endo K, Konishi J. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis. J Clin Endocrinol Metab 1988; 67: 251–258.
Nissim M, Lee K-O, Petrie PA, Dahlberg PA, Weintraub BD. A sensitive thyrotropin (TSH) bioassay based on iodide uptake in rat FRTL-5 thyroid cells: comparison with the adenosine 3′,5′-monophosphate response to human serum TSH and enzymatically deglycosylated bovine and human TSH. Endocrinology 1987; 121: 1278–1287.
Miller JM, Hamburger JI. The thyroid scintigram. I. The hot nodule. Radiology 1965; 84: 66–74.
Kasagi K, Takeda K, Goshi J, Takamatsu J, Hidaka A, Hatabu H, Misaki T, Iida Y, Kuma K, Konishi J. Presence of both stimulating and blocking types of TSH-receptor antibodies in sera from three patients with primary hypothyroidism. Clin Endocrinol (Oxf) 1990; 32: 253–260.
Studer H, Gebel F. Toxic nodular goitre. Clin Endocrinol Metab 1985; 14: 351–372.
Kraiem Z, Glaser B. Yigla M, Pauker J, Sadeh O, Sheinfeld M. Toxic multinodular goitre: a variant of autoimmune hyperthyroidism. J Clin Endocrinol Metab 1987; 65: 659–664.
Kasagi K, Hidaka A, Misaki T, Miyamoto S, Takeuchi R, Sakahara H, Sasayama S, Iida Y, Konishi J. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease. J Nucl Med 1994; 35: 811–817.
Paschke R, Bückner N, Eck T, Schaaf L, Back W, Usadel KH. Regional stimulation of thyroid epithelial cells in Graves' disease by lymphocytic aggregates and plasma cells. Acta Endocrinol Copenh 1991; 125: 459–465.
Charkes ND. Graves' disease with functioning nodules (Marine-Lenhart syndrome). J Nucl Med 1972; 13: 885–892.
Oertel JE; LiVolsi VA. Pathology of thyroid diseases. In: Ingbar SH, Braverman LW eds. The thyroid. Philadelphia:Lippincott; 1986: 651–686.
Amino N, Watanabe Y, Tamaki H, Iwatani Y, Miyai K. In-vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies. Clin Endocrinol (Oxf) 1987; 27: 615–624.
Kosugi S, Ban T, Akamizu T, Kohn LD. Use of thyrotropin receptor (TSHR) mutants to detect thyroid stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. J Clin Endocrinol Metab 1993; 77: 19–24.
Inoue D, Sato K, Sugawa H, Akamizu T, Maeda M, Inoko H, Tsuji K, Mori T. Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analysis of HLA-DP Loci. J Clin Endocrinol Metab 1993; 77: 606–610.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kasagi, K., Hatabu, H., Miyamoto, S. et al. Scintigraphic findings of the thyroid in hypothyroid patients with blocking-type TSH-receptor antibodies. Eur J Nucl Med 21, 962–967 (1994). https://doi.org/10.1007/BF00238120
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00238120